Skip to main content
# Title Department Research Member Research Year
171 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021
172 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
Department of Biostatistics and Cancer Epidemiology Basma Rezk Farouk Saleh 2021
173 Expression of programmed death ligand-1 (PDL-1) in Acute Myeloid Leukemia Patients and its relation to post induction Department of Clinical Pathology Lamyaa Ahmed Abdelhafeez Ahmed 2021
174 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
175 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021
176 Two-be SPECT/CT versus planar bone scintigraphy: Prospective comparison of reproducibility and diagnostic performance Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
177 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Mohamed Ismail Omar Ali 2021
178 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2021
179 Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma Department of Radiotherapy and Nuclear medicine Dr. Esraa Roshdy Hassan Mohamed 2021
180 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021